Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01856270 : Amitriptyline to Prevent Headache After Traumatic Brain Injury
PhasePhase 2
AgesMin: 18 Years Max: 60 Years
Eligibility
Inclusion Criteria:

- Acute mild TBI (Glasgow Coma Scale of 13-15 on emergency department evaluation, any
period of loss of consciousness (LOC) < than 30 minutes, alteration of consciousness
or post-traumatic amnesia (not to exceed 24 hours)

- Ability to give consent

- Ages 18-60

- Access to a telephone

- Current headache (new headache or headache worse than prior to injury)

Exclusion Criteria:

- Does not speak English

- Diagnosed seizure disorder

- Myocardial infarction in prior 6 months

- Cardiac arrhythmia requiring medication treatment

- Prolonged Q-T interval on electrocardiogram

- Psychosis

- Intoxication on hospital admission sufficient enough to cloud the diagnosis of mild
TBI

- Incarceration or homelessness

- Allergy to amitriptyline

- Current treatment with amitriptyline or other tricyclic antidepressant

- Currently taking any medication not recommended for use with amitriptyline due to the
potential for Q-T interval prolongation. Examples of this include: Class I, I-A or
II antiarrhythmics, TCA's, MAOI's, selected fluoroquinolones (gatifloxacin,
moxifloxacin), selected antipsychotic medications (haloperidol, risperidone,
quetiapine), selected antiretroviral medications, cisapride, chloroquine,
chlorpromazine, prochlorperazine, promethazine, citalopram, fluoxetine, erythromycin,
methadone

- History of glaucoma

- History of prostate disease or current urinary retention
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01856270      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740